Counseling Points - October 2007 - (Page 14)

Counseling Points™ Rheumatoid Arthritis: Epidemiology, Symptomatology, and Natural History of the Disease Process Continuing Education Posttest To receive credit, please read the newsletter in its entirety and answer the posttest and program evaluation questions using the answer key on page 15. Please mail or fax the form to Delaware Media Group, 66 South Maple Ave., Ridgewood, NJ 07450, Fax (201) 612-8282. (If you are completing the posttest online, simply hit the “submit” button.) A certificate from the Infusion Nurses Society will be awarded for a score of 80% (8 correct) or better. A certificate will be mailed within 4 to 6 weeks.There is no charge for CE credit. 1. Without treatment, of individuals with rheumatoid arthritis (RA) become permanently work-disabled within 2 to 3 years of diagnosis. A) 10% to 20% B) 20% to 30% C) 50% D) 73% 2. RA develops typically between the ages of: A) 5 to 10 years B) 10 to 25 years C) 35 to 50 years D) 50 to 75 years 3. RA affects of the population worldwide. A) 1% B) 9% C) 15% D) 24% 4. On average, patients with RA have co-morbidities. A) one B) two or more C) two or less D) no 5. A study by Maetzel and colleagues found that the estimated total annual costs for RA patients were: A) $3,900 B) $5,700 C) $9,300 D) $15,800 6. Which factors play a role in the etiology of RA? A) Genetic make-up B) Smoking C) Female sex D) All of the above 7. The three main proinflammatory cytokines involved in the pathogenesis of RA are: A) TNF-α, IL-1, IL-4 B) INF-γ, IL-11, IL-18 C) TNF-α, IL-1, IL-6 D) none of the above 8. Identify the symptoms below that are part of the American College of Rheumatology diagnostic criteria for RA: A) over 50 years of age, less than 30 minutes of morning stiffness, pain associated with internal hip, bony overgrowths B) morning stiffness for more than 1 hour, arthritis of more than three joints, symmetric arthritis, arthritis of hand joints C) evening stiffness for more than 1 hour, arthritis of more than two joints, symmetric arthritis D) all of the above 9. The three primary classes of medications used to treat RA are: A) Nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs) B) NSAIDs, beta-blockers, opiates C) Opiates, anticoagulants, DMARDs D) Antiplatelet medications, corticosteroids, proton-pump inhibitors 10. Biological response-modifying DMARDs have more rapid mechanisms of action and a preferred dosing schedule than conventional DMARDs. A) True B) False COUNSELING POINTS™ 14

Table of Contents Feed for the Digital Edition of Counseling Points - October 2007

Counseling Points - October 2007 Welcome Introduction Overview of RA RA Morbidity and Mortality RA Costs and Quality of Life RA Risk Factors Pathophysiology of RA Diagnosis and Natural History of RA Diagnostic Tests and Radiography Natural History and Progression of RA Disease Management Treatment Strategies Summary Continuing Education Posttest Evaluation Form

Counseling Points - October 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.